SPARC is downregulated in MDS [33] and upregulated in AML carrying the t(8;12) or inv(16) rearrangement [34] and SPARC overexpression promotes Imatinib resistance in chronic myeloid leukemia [35]. This evidence concerns the gene SPARC and chronic myelogenous leukemia, BCR-ABL1 positive.